Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 31.20 | 31.20 | 0.00 |
| Shares | 64.91 | 72.17 | 7.26 |
| Other | 3.90 | 3.90 | 0.00 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 14.07 | 17.01 |
| Price to Book | 2.19 | 2.22 |
| Price to Sales | 1.76 | 1.59 |
| Price to Cash Flow | 10.38 | 9.41 |
| Dividend Yield | 0.84 | 1.46 |
| 5 Years Earnings Growth | 3.07 | 8.49 |
| Name | Net % | Category Average |
|---|---|---|
| Financial Services | 25.34 | 17.79 |
| Healthcare | 25.31 | 17.89 |
| Consumer Cyclical | 18.06 | 10.06 |
| Consumer Defensive | 12.91 | 9.70 |
| Industrials | 9.30 | 8.94 |
| Technology | 7.08 | 15.62 |
| Real Estate | 2.00 | 1.91 |
| Energy | -0.01 | 4.67 |
Number of long holdings: 23
Number of short holdings: 12
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Dun & Bradstreet Holdings Inc Ordinary Shares | US26484T1060 | 11.22 | - | - | |
| SpringWorks Therapeutics Inc Ordinary Shares | US85205L1070 | 10.46 | - | - | |
| Skechers USA Inc Class A | US8305661055 | 10.33 | - | - | |
| Kellanova | US4878361082 | 8.40 | 83.32 | +0.04% | |
| Enstar Group Ltd | BMG3075P1014 | 7.40 | - | - | |
| Blueprint Medicines Corp | US09627Y1091 | 6.78 | - | - | |
| The AZEK Co Inc Class A | US05478C1053 | 6.33 | - | - | |
| AvidXchange Holdings Inc | - | 4.03 | - | - | |
| ChampionX Corp | US15872M1045 | 1.70 | - | - | |
| Redfin Corp | US75737F1084 | 1.36 | - | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Vivaldi Multi-Strategy I | 1.1B | 6.08 | 8.00 | 4.59 | ||
| Vivaldi Multi Strategy Fund Class A | 33.3M | 8.07 | 3.56 | 4.01 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review